文献速递肿瘤 PET/CT

68Ga-PSMA PET/CT偶然发现脂肪肉瘤示踪剂摄取

Incidental Detection of Tracer Avidity in Liposarcoma on 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT.
PubMed 文献 · Clin Nucl Med · 2018-01-01

本文报告一例76岁男性因疑似前列腺癌行68Ga-PSMA PET/CT,全身显像发现左侧缝匠肌脂肪性病变有示踪剂摄取,组织病理学检查证实为高分化脂肪肉瘤。文章提示68Ga-PSMA在非前列腺良恶性病变中可出现非特异性摄取。

要点

  • 68Ga-PSMA PET/CT在前列腺癌分期和复发检测中诊断性能优异,正成为新的参考标准。
  • 近期已有多个孤立报告关于68Ga-PSMA在非前列腺良性或恶性病变中的非特异性摄取。
  • 本例76岁男性疑似前列腺癌患者,左侧缝匠肌脂肪性病变显示示踪剂摄取,病理为高分化脂肪肉瘤。

核心结论

  • 68Ga-PSMA PET/CT在非前列腺良性或恶性病变中可出现非特异性摄取,本例为左侧缝匠肌高分化脂肪肉瘤显示示踪剂摄取。

研究设计与样本

  • 个案报告:一例76岁男性因疑似前列腺癌行68Ga-PSMA PET/CT检查。

主要发现

  • 全身PET/CT显示左侧缝匠肌脂肪性病变有示踪剂摄取,组织病理学检查证实为高分化脂肪肉瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT is emerging as new reference standard for imaging of prostate cancer because of superb diagnostic performance in disease staging and recurrence detection. However, a number of isolated reports have been published recently regarding the nonspecific uptake of Ga-PSMA in nonprostatic benign or malignant pathologies. We describe the case of a 76-year-old man who underwent Ga-labeled PSMA PET/CT for suspicion of prostate cancer. Whole-body PET/CT of whom revealed tracer avidity in lipomatous lesion involving the left sartorius muscle. Histopathologic examination of lesion revealed a well-differentiated liposarcoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Malik D, Mittal BR, Kumar R, et al. Incidental Detection of Tracer Avidity in Liposarcoma on 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT. Clin Nucl Med. 2018. PMID: 30080189. doi:10.1097/RLU.0000000000002189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。